Mark Lythgoe: Big rise in number of UK cancers – post-pandemic effect or better early detection

Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared on X:

“Big rise in number of UK cancers especially prostate cancer – post-pandemic effect or better early detection?

Certainly more resources needed.”

Mark Lythgoe is a Clinical Research Fellow in Medical Oncology at Imperial College London and a Specialist Registrar/Academic Clinical Fellow at Imperial College Healthcare NHS Trust. His research focuses on oncology therapy and drug development, in collaboration with global pharmaceutical companies to develop new cancer therapies.

His other research interests include early-phase oncology studies, biomarker development, intra-tumoral microbiome analysis, Mendelian randomization, and meta-data analysis.